Protein Expression Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The protein expression market is Segmented By Product (Reagent and Kits, Service, Other Products), By Application (Therapeutic, Industrial, Research), By End User (Academia, Biotechnology & Pharmaceuticals Companies, Contract Research Organizations (CROs),)and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

protein expression market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 11.33 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Protein Expression Market is expected to register a CAGR of 11.33% during the forecast period with a revenue of USD 2,047.91 million in 2020, and it is expected to reach USD 3,718.34 million by 2026.

The market has a slightly positive impact due to the pandemic. The development of therapeutic and preventive strategies requires an accurate understanding of the role that proteins play in the SARS-CoV-2 infection process and progression of COVID-19. The vast field of proteomics is well equipped with the technologies needed to help in facing this challenge. In an article published in October 2020 in the Journal of Proteins and Proteomics, researchers have highlighted that developments in proteome technologies will not only accelerate progress in addressing the coronavirus pandemics but could also prove invaluable in tackling the current COVID-19 crisis.

The propelling factors for the growth of the protein expression market include the rise in the R&D activity in the pharmaceutical sector, opportunities in the field of proteomics, advancements in the biologics market set to boost the market growth, and increasing incidences of chronic diseases. As per the World Health Organization 2020, the major chronic diseases such as cardiovascular diseases (CVD), cancer, chronic obstructive pulmonary disease and type 2 diabetes are estimated to account to 73% of all deaths and 60% of the global burden of diseases in 2020.

Biologics have played a crucial role in the treatment process of many health issues. The success of Humira, a drug for the treatment of rheumatoid arthritis, has been an encouraging factor for many drug makers to continue working in the pathway of biologics. The growing demand for biologicals increase the prospects of its manufacturing using the protein expression systmens boosting the market growth.

In addition the biotechnology-based organizations have also created a big opportunity for the protein expression market growth by developing novel therapeutics with minimal side effects. The increasing research intensity in the pharmaceutical sector is adding up to the opportunities for growth.

Therefore at present, the protein expression market is a highly attractive and profitable market due to the increasing adoption of biotechnology as well as genetic engineering in the pharmaceutical industry and medical science. However, the high cost of protein expression systems and lack of effective systems for post-translational modifications are expected to restrain the market growth over the forecast period.

Scope of the Report

As per the scope of the report, protein expression is the way in which proteins are modified, synthesized, and regulated in living organisms. The term is applicable to either the object of study or the laboratory techniques required to manufacture proteins. Proteins are regulated and synthesized depending upon the functional need in the host cell. The translation, transcription, and post-translational modifications are the three processes involved in protein expression. The protein expression market is Segmented By Product (Reagent and Kits, Service, Other Products), By Application (Therapeutic, Industrial, Research), By End User (Academia, Biotechnology & Pharmaceuticals Companies, Contract Research Organizations (CROs),)and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product
Reagents and Kits
Cell-Free Expression
Bacterial Expression
Yeast Expression
Algal Expression
Insect Expression
Mammalian Expression
Other Expression Systems
Service
Others
By Application
Therapeutic
Industrial
Research
By End User
Academia
Biotechnology & Pharmaceuticals Companies
Contract Research Organizations (CROs)
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cell Free Expression is Expected to Hold a Major Market Share in the Protein Expression Market

The cell-free protein expression is well-established in the market, due to the acceptance of it and this protein expression is performed without the use of living cells. This technique has many advantages over other protein expression techniques and because of its advantages, it is widely used. Due to the advantages of cell-free protein techniques, such as increased speed, ability to express toxic proteins, ease of amino acid type selective labeling, among others, these are making the cell expression market grow.

Furthermore, the growing launches of cell-free systems boost the usage of the kits and reagents. For instance, in 2019, Arbor Biosciences announced the launch of myTXTLTM bulk offerings of cell-free expression systems. These new offerings align with the growing demand for larger volume requirements by organizations utilizing high-throughput screening in protein and enzyme engineering. These cell-free expression systems are currently available from Arbor Biosciences as a Sigma 70 or a linear DNA expression master mix

Moreover, the growing research and studies on cell-free systems, especially due to COVID is further boosting the growth of the segment. The article ‘Combating COVID-19 with Cell-Free Expression’ published in October 2020, synthetic biologists pivoted the cell-free expression technology that they were using for other diseases to develop new diagnostics, materials, and treatments specifically for COVID-19.

Therefore, the unique technology may increase the growth of the cell-free expression market, which in turn, is expected to boost the protein expression market.

caner

North America is the Largest Growing Market that is Expected to Continue the Same Trend Over the Forecast Period

North America is the largest market for protein expression and is expected to dominate the overall protein expression market due to factors like the presence of well-established healthcare infrastructure in these regions combined with the intense R&D activities carried out. The United States protein expression market is driven by factors, such as an increase in the usage of protein technologies, the rapid evolution of the pharmaceutical industry in the region, and the presence of several companies in the region itself. 

As per the January 2021 report of the American Cancer Society, there will be an estimated 1,898,160 new cases of cancer, and 608,570 people will die from it. The increasing demand and acceptance of gene and monoclonal antibody-based therapies in the treatment of diseases such as cancer, rare diseases, and other disorders are also driving the growth of the protein expression market in the region.

According to the Statistics Canada May 2021 report titled “ The Canadian Research and Development Pharmaceutical Sector,” in 2018, the pharmaceutical sector added almost USD 15 billion in value-added to the Canadian economy and spent about USD 1.5 billion to USD 2 billion on research and development during the same period of time.

The growing patient population and growing research and development funding in the region is boosting the market growth 

Protein Expression Market2

Competitive Landscape

The Protein Expression Market is fragmented competitive. The companies present have a broad product portfolio with comprehensive features and have a strong geographical presence. Furthermore, these leaders cater to the requirements of major end users, such as research laboratories and pharmaceutical and biotechnology companies. Some of the companies which are currently dominating the market are Agilent Technologies Inc., Bio-Rad Technologies, Thermo Fisher Scientific Inc., Merck KGA, Takara Bio Inc., New England Biolabs Inc., Oxford Expression Technologies Ltd, Promega Corporation, Qiagen NV, and Sigma-Aldrich Corporation.

RECENT DEVELOPMENTS

  • In June 2021, Qiagen launched CRISPR products for the analysis of edited genetic material with high speed and efficiency. The products were QIAprep&amp CRISPR kit and CRISPR Q-Primer Solution.
  • In October 2020, Merck launched the Virus Express Lentiviral Production Platform, which can reduce process development time by approximately 40%.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising R&D Activity in the Pharmaceutical Sector

      2. 4.2.2 Escalation in the Biologics Market

      3. 4.2.3 Government Support for Proteomics and Genomics Research

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Protein Expression Systems

      2. 4.3.2 Lack Of Effective Systems For Post-translational Modifications

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Reagents and Kits

        1. 5.1.1.1 Cell-Free Expression

        2. 5.1.1.2 Bacterial Expression

        3. 5.1.1.3 Yeast Expression

        4. 5.1.1.4 Algal Expression

        5. 5.1.1.5 Insect Expression

        6. 5.1.1.6 Mammalian Expression

        7. 5.1.1.7 Other Expression Systems

      2. 5.1.2 Service

      3. 5.1.3 Others

    2. 5.2 By Application

      1. 5.2.1 Therapeutic

      2. 5.2.2 Industrial

      3. 5.2.3 Research

    3. 5.3 By End User

      1. 5.3.1 Academia

      2. 5.3.2 Biotechnology & Pharmaceuticals Companies

      3. 5.3.3 Contract Research Organizations (CROs)

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies Inc.

      2. 6.1.2 Bio-Rad Laboratories Inc.

      3. 6.1.3 Merck KGaA

      4. 6.1.4 New England Biolabs Inc.

      5. 6.1.5 Oxford Expression

      6. 6.1.6 Promega Corporation

      7. 6.1.7 Qiagen NV

      8. 6.1.8 Takara Bio, Inc.

      9. 6.1.9 Thermo Fisher Scientific Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Protein Expression Market market is studied from 2018 - 2026.

The Global Protein Expression Market is growing at a CAGR of 11.33% over the next 5 years.

The Global Protein Expression Market is valued at 2047 Million USD in 2018.

The Global Protein Expression Market is valued at 3718 Million USD in 2026.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Agilent Technologies Inc, Thermo Fisher Scientific Inc, Merck KGaA, Takara Bio Inc, New England Biolabs Inc are the major companies operating in Global Protein Expression Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!